期刊文献+

老年代谢综合征患者血清炎性因子及脂联素水平与轻度认知功能障碍的关系 被引量:13

The relationship of serum levels of matrix metalloproteinase-9, intercellular adhesion molecule-I and adiponectin with the mild cognitive impairment in senile metabolic syndrome patients
原文传递
导出
摘要 目的探讨老年代谢综合征(metabolic syndrome,MS)患者血清基质金属蛋白酶(MMP)9、细胞问黏附因子(ICAM1)、脂联素水平与认知功能的相关性。方法采用多种神经心理学量表对MS患者74例和健康对照者30例进行认知功能评定,并测量其体质指数(BMI)、腹围、血压及检测空腹血糖(FBG)、血脂等代谢指标;将MS患者再分为MS+轻度认知功能障碍(MCI)组(39例)和MS组(35例);测定所有受试者的MMP-9、ICAM—1和脂联素水平。结果(1)MS+MCI组的BMI、收缩压、FBG、三酰甘油(TG)水平均高于MS组及对照组(P〈0.05)。MS+MCI组、MS组血清MMP-9、ICAM-1的水平明显高于对照组(P〈0.01),而脂联素水平明显低于对照组(x^2=26.62,P〈0.01);MS+MCI组血清MMP-9水平明显高于MS组(z=-4.61,P〈0.05),脂联素水平明显低于MS组(Z=-5.77,P〈0.05);(2)Spearman直线相关分析显示,MS+MCI组、MS组血清MMP9(r=-0.794,P〈0.001)、ICAM-1(r=0.501,P〈0.001)与脂联素显著负相关,MMP9与ICAM-1之间显著正相关(r=0.481,P=0.006);(3)多重线性回归分析显示,蒙特利尔认知评估量表(MoCA)评分与MMP-9(β=-3.438,P=0.001)、脂联素(β=1.337,P=0.006)、收缩压(β=-0.058,P=0.003)、FBG(β=-0.227,P=0.049)具有线性相关关系;(4)多因素Logisic逐步回归分析结果显示,高MMP-9(OR=1.007)、低脂联素(OR=0.359)水平是老年MS患者发生认知功能障碍的危险因素。结论老年MS患者存在认知功能损害;MCI患者血清炎症因子表达增加,且与代谢异常存在相关性;MMP-9可能促进神经退行性变,而脂联素在这一过程中起到保护作用,表明炎性反应参与老年MS患者MCI的病理过程。 Objective To evaluate the relationships of the serum levels of matrix metalloproteinase 9 (MMP 9), intercellular adhesion molecule-1 (ICAM-1) and adiponectin with the mild cognitive impairment (MCI) in senile metabolic syndrome (MS)patients. Methods The 74 cases with MS and 30 health controls (control group) were enrolled. Mini-mental state examination (MMSE), montreal cognitive assessment (MoCA), digit-symbol test (DST), auditory verbal memory test (AVMT), trail making test(TMT), sunderland clock drawing test (CDT) and verbal fluency test (VFT) were applied to evaluate cognitive function. Based on the cognitive assessment, MS patients were divided into two groups: 39 cases with MCI (MS+ MCI group) and 35 cases without cognitive impairment (MS group). The levels of MMP-9, ICAM-1 and adiponectin were measured by ELISA. Biochemical variables were measured by routine methods in all subjects. Results (1)MS+ MCI group showed the higher levels of BMI, SBP, FBG and MMP-9 (all P〈0. 05) and lower level of adiponectin (P〈0.05) than did the MS group. And MS group had higher levels of MMP-9 and ICAM-1 (P〈0.01) and lower adiponectin level (P〈0.01) than did the control group. (2)Spearman' s correlation analysis showed that the serum levels of MMP 9 (r=-0. 794, P〈0. 001) and ICAM-1 (r = -0. 501, P〈0. 001) were negatively correlated with adiponectin. However, MMP-9 was positively correlated with ICAM-1 ( r=0. 481, P= 0. 006). ( 3 ) Multiple linear regression analysis indicated that there was linear relationship of MoCA with MMP 9 (β= 3. 438, P=0. 0019), adiponectin (β=1.337, P=0.006), SBP (β=-0.058, P=0.003) and FBG (β=-0.227, P 0. 049). (4) Stepwise logistic analysis showed that both high MMP-9 (OR 1. 007) and low adiponectin (OR= 0.359) were risk factors for the decline of cognitive function. Conclusions Elderly patients with MS may show deterioration in memory, calculation and visuospatial perception. Elevated inflammatory factors might contribute, in combination with abnormal metabolism, to MCI. MMP-9 might contribute to neuronal degeneration. However, adiponectin could strongly counteract the risk factors for cognitive impairment.
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2011年第5期405-409,共5页 Chinese Journal of Geriatrics
基金 山东省保健医学科研课题项目(2007BZll)
关键词 代谢综合征X 认知障碍 基质金属蛋白酶9 细胞黏附因子1 脂联素 Metabolic syndrome X Cognitive impairment Matrix metalloproteinase 9 Intercellular adhesion molecule 1 Adiponectin
  • 相关文献

参考文献16

  • 1Segura B, Jurado MA. Metabolic syndrome and ageing : cognitive impairment andstructural alterations of the central nervous system. Rev Neurol, 2009, 49:417-424.
  • 2Vlachopoulos C, Rokkas K, Ioakeimidis N, et al. Inflammation, metabolic syndrome, erectile dysfunction, and coronary artery disease: common links. Eur Urol, 2007, 52:1590 -1600.
  • 3PetersenRC, Smith G, Waring SC, et al. Mild cognitive impairment: Clinical characterization and outcome. Arch Neurology, 1999, 56:303-308.
  • 4宋秀霞 ,纪立农 .国际糖尿病联盟代谢综合征全球共识定义[J].中华糖尿病杂志(1006-6187),2005,13(3):178-180. 被引量:610
  • 5Yaffe K, Kanaya A, I.indquist K, et al. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA, 2004, 292:2237-2242.
  • 6Goncalves FM, Jacob-Ferreira AI., Gomes VA, et al. Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro inflammatory markers in patients with metabolic syndrome. ClinChim Acta, 2009, 403: 173-177.
  • 7Cicero AF, Derosa G, Manca M, et al. Vascular remodeling and prothrombotie markers in subjects affected by familial combined hyperlipidemia and/or metabolic syndrome in primary prevention for cardiovascular disease. Endothelium, 2007, 14: 193-198.
  • 8Wang J, I.i H, Franco OH, et al. Adiponectin and metabolic syndrome in middle aged and elderly Chinese. Obesity, 2008, 16:172-178.
  • 9Dik MG,Penninx B, Comijs HC, et al. Contribution of Metabolic syndrome components to cognition in old individuals. Diabetes Care, 2007, 30: 2655-2660.
  • 10Bruno MA, Mufson EJ, Wuu J, et al. Increased matrix metalloproteinase 9 activity in mild cognitive impairment. J Neuropathol Exp Neurol, 2009, 68: 1309-1318.

二级参考文献31

  • 1Alberti KG, Zimmet P, Shaw J . The metabolic syndrome-a new worldwide definition. Lancet, 2005, 366:1059-1062.
  • 2Haffner SM, Miettinen H, Stern MP. The homeostasis model in the San Antonio Heart Study. Diabetes Care, 1997,20 : 1087-1092.
  • 3Lyon CJ, Law RE, Hsueh WA. Adiposity, inflammation, and atherogenesis. Endocrinology, 2003, 144 : 2195-2200.
  • 4Guzik TJ, Mangalat D, Korbut R. Adipoeytokines - novel link between inflammation and vascular function? Physiol Pharmacol, 2006, 57 : 505-528.
  • 5Danenberq HD, Kantak N, Grad E, et al. C-reactive protein promotes monocyte-platelet aggregation: an additional link to the inflammatory-thrombotlc intricacy. Eur J Haematol, 2007,78 : 246-252.
  • 6Reilly MP, Rohatgi A, McMahon KJ, et al. Plasma cytokines, metabolic syndrome, and atherosclerosis in humans. Investig Med, 2007,55 : 26-35.
  • 7Kempf K, Rose B, Herder C, et al. The metabolic syndrome sensitizes leukocytes for glucose-induced immune gene expression. Mol Med, 2007,85:389-396.
  • 8Trujillo ME, Scherer PE. Adiponectin-journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. Internal Med, 2005,257 : 167-175.
  • 9Nesto RW. The relation of insulin resistance syndromes to risk of cardiovascular disease. Rev Cardiovasc Med,2003,4(suppl 6):s11-s18.
  • 10Pouliot MC, Després JP, Lemieux S, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol,1994,73:460-468.

共引文献611

同被引文献102

引证文献13

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部